Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT05029466
Psilocybin for Treatment-Resistant Depression
Phase: Phase 2
Role: Collaborator
Start: Nov 19, 2021
Completion: Jul 22, 2023